Glioblastoma Clinical Trials in San Diego, CA

View the best 10 glioblastoma medical studies in San Diego, California. Access promising new therapies by applying to a San Diego-based Glioblastoma clinical trial.

Trials in San Diego, California

Here are the top 10 medical studies for glioblastoma in San Diego, California

Radiation Therapy +2 More

Radiation

Recruiting1 awardPhase 1 & 2

This trial will test a new treatment, DB107-RRV and DB107-FC, in combination with standard care for patients with newly diagnosed High Grade Glioma (HGG) following surgical

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3

This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2

This trial tests a combination of tocilizumab, atezolizumab, and precise radiation therapy in patients with recurrent glioblastoma. Tocilizumab reduces inflammation, atezolizumab boosts the immune system, and the radiation targets the tumor. The goal is to make the tumor more responsive to treatment and improve patient outcomes.

Optune®

Device

Recruiting1 award12 criteria

This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.

Niraparib

PARP Inhibitor

Recruiting2 awardsPhase 3

"This trial will compare two drugs, niraparib and temozolomide, to see which one is more effective for treating a specific type of brain cancer called glioblastoma. The

Autologous genetically modified gamma-delta T cells +1 More

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2

This trial tests if a cell therapy can delay cancer return in GBM patients when combined with standard chemo. If it works, it should be studied further.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.

Temozolomide +1 More

Chemotherapy

Recruiting1 awardPhase 3

This trial is testing a treatment for newly diagnosed brain cancer patients. They are comparing the effectiveness of a new treatment called Optune with chemotherapy and immunotherapy to a combination of Optune with chemotherapy alone.

Lomustine +1 More

Chemotherapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new combination of drugs to treat adults with gliomas, with the goal of finding a safe and effective treatment.

NanO2TM

Oxygen Enhancer

Recruiting0 awardsPhase 2

This trial is testing a new treatment that delivers more oxygen to tumors. It aims to help patients with a specific type of brain cancer by making radiation therapy more effective. By increasing oxygen levels in the tumor, the treatment helps radiation work better at killing cancer cells.

Popular Filters

Trials With No Placebo

Radiation

DB107-RRV + DB107-FC for Brain Tumors

Recruiting1 awardPhase 1 & 2

San Diego, California

This trial will test a new treatment, DB107-RRV and DB107-FC, in combination with standard care for patients with newly diagnosed High Grade Glioma (HGG) following surgical

PARP Inhibitor

Niraparib vs Temozolomide for Brain Cancer

Recruiting2 awardsPhase 3

La Jolla, California

"This trial will compare two drugs, niraparib and temozolomide, to see which one is more effective for treating a specific type of brain cancer called glioblastoma. The

Monoclonal Antibodies

N-803 + PD-L1 t-haNK + Bevacizumab for Glioblastoma

Recruiting1 awardPhase 2

Newport Beach, California

This trial is testing the safety and effectiveness of a combination treatment for subjects with recurrent or progressive GBM using N-803, PD-L1 t-haNK, and Bevacizumab.

LP-184 for Solid Tumors

Recruiting1 awardPhase 1 & 2

Los Alamitos, California

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

CAR T-cell Therapy

Gene-Modified T Cell Therapy for Glioblastoma

Recruiting1 awardPhase 1 & 2

La Jolla, California

This trial tests if a cell therapy can delay cancer return in GBM patients when combined with standard chemo. If it works, it should be studied further.

Selective Inhibitor of Nuclear Export

Selinexor + Temozolomide for Recurrent Glioblastoma

Recruiting1 awardPhase 1 & 2

La Jolla, California

This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.